Vaccines represent the greatest achievements of one area of science for increasing our health and well-being. This collection of papers represents the latest advances in bacterial vaccine research. The papers presented at this symposium illustrate the increasing potential and need for continuing research into disease pathogenesis, host resistance mechanisms, and vaccine development. Further, the study of bacterial vaccines provides an important method for characterizing pathogenic mechanisms and natural and induced host resistance mechanisms.
Inhaltsverzeichnis
Development of pneumococcal vaccine, R.Austrian; efficacy of the 14-valent pneumococcal vaccine in selected populations in the US, G.Bolan et al; antibody responses of elderly persons immunized with pneumococcal polysaccharide vaccine, M.Mufson and G.Schiffman; immunization of adults and geriatric patients, G.Stollerman; ontogeny of human antibody responses to bacterial capsular polysaccharides, R.Insel; compensation for vaccine-related injuries, R.Kingham; potential use of antidiotype antibodies as vaccines, M.Gurish and A.Nisonoff; oral shigella vaccines, E.Tramont and S.Formal; field trials of efficacy of attenuated salmonella typhi oral vaccine strain TY21A, M.Levine et al; development of a recombinant live oral cholera vaccine, J.Kaper et al; genetic analysis of bordetella pertussis and its implications for designing a new pertussis vaccine, S.Stibitz et al; protective epitopes of streptococcal M. proteins, J.Seyer et al; an escherichia coli pilus peptide vaccine prevents renal colonization and infection in balb, C.Mice et al; antibodies to peptides corresponding to a conserved sequence among gonococcal pili block bacterial adhesion, J.Rothbard and G.Schoolnik; synthetic peptide conjugates as probes for anti-cholera/coli heat labile toxin vaccine, C.Jacob.